logo

For the Inventor, By the Inventor

Frederick, MD, United States of America

Robert C Moschel

This inventor holds 15 USPTO granted patents, plus 1 CIPO patent. Top assignees: The Penn State Research Foundation, Arch Development Corporation, The United States of America as Represented by the Department of Health. Active years: 1992-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert C Moschel. Retrieved from https://idiyas.com/inventor/robert-c-moschel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 93.3

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 120(Granted Patents)


Company Filing History:

goldMedal9 out of 1,340 
 
The Penn State Research Foundation
 patents
silverMedal6 out of 349 
 
Arch Development Corporation
 patents
bronzeMedal5 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
4. 3 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
5. 2 out of 3,696 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
6. 1 out of 1 
 
The of the United States of America as Represented by the Department of
 patent
7. 4 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2012

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8188055 - Inactivators of O6-alkylguanine-DNA alkyltransferase (2012-05-29),
2. 7825096 - O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs (2010-11-02),
3. 6436945 - Substituted O6-benzyl-8-aza-guanines (2002-08-20),
4. 6333331 - Substituted O6-benzylguanines (2001-12-25),
5. 6303604 - Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase (2001-10-16),
6. 6172070 - Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines (2001-01-09),
7. 6060458 - Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use (2000-05-09),
8. 5958932 - Substitutes O.sup.6 -benzylguanines, compositions, and methods of using (1999-09-28),
9. 5916894 - Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines (1999-06-29),
10. 5753668 - Substituted benzyloxypyrimidines and their inactivation of O.sup.6 (1998-05-19),
11. 5691307 - O.sup.6 -substituted guanine compositions and methods for depleting O.sup.6 (1997-11-25),
12. 5525606 - Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines (1996-06-11),
13. 5358952 - O.sup.6 -substituted guanine compounds and methods for depleting O.sup.6 (1994-10-25),
14. 5352669 - O.sup.6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds (1994-10-04),
15. 5091430 - O.sup.6 -substituted guanine compounds and methods for depleting O.sup.6 (1992-02-25),
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…